Manuel Litchman
Directeur Général chez MUSTANG BIO, INC.
Fortune : 29 058 $ au 30/04/2024
Postes actifs de Manuel Litchman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MUSTANG BIO, INC. | Directeur/Membre du Conseil | 24/04/2017 | - |
| Directeur Général | 24/04/2017 | - | |
| President | 24/04/2017 | - | |
| Directeur Financier/CFO | 11/12/2023 | 19/01/2024 |
Historique de carrière de Manuel Litchman
Anciens postes connus de Manuel Litchman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/08/2012 | 01/12/2014 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - | - |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Directeur/Membre du Conseil | 12/01/2015 | - |
| Directeur Général | 12/01/2015 | - | |
| President | 12/01/2015 | - |
Formation de Manuel Litchman
| Princeton University | Undergraduate Degree |
| Yale School of Medicine | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Suisse | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| President | 2 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MUSTANG BIO, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
- Bourse
- Insiders
- Manuel Litchman
- Expérience
